Qualigen Therapeutics Inc share price logo

Qualigen Therapeutics Inc Share Price

NASDAQ: QLGN

Small Cap

$3.89

+0.25

(+6.87%)

as on

Qualigen Therapeutics Inc Stock Performance

as on October 21, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $3.64
    $4.06
    downward going graph

    6.43%

    Downside

    4.37%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.61
    $10.45
    downward going graph

    58.61%

    Downside

    168.64%

    Upside

    downward going graph

Qualigen Therapeutics Inc share price movements today

Previous Close
$3.64
Open
$3.70
Volume
210.7K
Day's Low - High
$3.64 - $4.06
52 Week Low - High
$1.61 - $10.45

Qualigen Therapeutics Inc Historical Returns

1 Month Return
+ 38.38 %
3 Month Return
+ 28.01 %
1 Year Return
-56.93 %
3 Year Return
-96.8 %
5 Year Return
-99.82 %

Qualigen Therapeutics Inc Stock Fundamentals & Key Indicators

Check Qualigen Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.4M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.58

Industry PE ratio

0

PEG Ratio

0

EBITDA

-6.9M

Revenue (TTM)

5.0M

Profit Margin

0.00%

Return On Equity TTM

-841.66%

Qualigen Therapeutics Inc Stock Valuation

Track how Qualigen Therapeutics Inc P/E has moved over time to understand its valuation trends.

Qualigen Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-98.55x)

December 31, 2021

Industry (0.00x)

October 21, 2025

Today (0.58x)

October 21, 2025

Highest (182.95x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 0.58x

Qualigen Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Qualigen Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$7.4M-99.82%0.580.00%
BUY$35.5B359.02%-16.34-259.82%
BUY$63.1B259.92%-505.15-12.96%
BUY$106.9B98.27%29.6731.86%
BUY$61.3B0.76%14.5831.37%

Stock Returns calculator for Qualigen Therapeutics Inc Stock including INR - Dollar returns

The Qualigen Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Qualigen Therapeutics Inc investment value today

Current value as on today

₹47,384

Returns

₹52,616

(-52.62%)

Returns from Qualigen Therapeutics Inc Stock

₹57,346 (-57.35%)

Dollar Returns*

₹4,730 (+4.73%)

Analyst Recommendation on Qualigen Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Qualigen Therapeutics Inc. Average target price of $5

Qualigen Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Qualigen Therapeutics Inc.

What analysts predicted

22.2%UPSIDE

Target Price

$5

Current Price

$3.89

Analyzed by

7 Analysts

Target

$5.00

Qualigen Therapeutics Inc target price $5, a slight upside of 22.2% compared to current price of $3.89. According to 7 analysts rating.

Qualigen Therapeutics Inc Stock’s Investor Sentiment and Interest

Investment in Qualigen Therapeutics Inc Shares on INDmoney has grown by 1010.00% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:1010.00% versus previous 30 day period

Search interest for Qualigen Therapeutics Inc Stock has increased by 630% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:630% versus previous 30 day period

Qualigen Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
1
1
7
-
-
-
-
-
2
-
Gross Profit
0
0
2
0
0
0
0
-
1
-
Operating Income
-3
-3
-2
-2
-1
-1
-1
0
-1
-1
EBITDA
-3
-3
-2
-2
-1
-1
-1
-
0
-1
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
-
-
-
-
-
-
Income Before Tax
-4
-3
-3
-2
-2
-1
-1
0
0
-1
Income Tax Expense
0
0
0
0
0
0
0
-
0
0
Net Income
-4
-3
-3
-2
-2
-1
-1
0
0
-1
Net Profit Margin
-255.56%
-212.92%
-46.03%
0.00%
0.00%
0.00%
0.00%
0.00%
-38.25%
0.00%

Qualigen Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
9
5
5
4
5
4
5
-
Gross Profit
-7
-16
1
-2
1
0
0
-
Operating Income
-15
-33
-1
-11
-22
-17
-11
-5
EBITDA
-15
-33
-10
-11
-22
-13
-11
-5
Interest Expense
-
-
0
0
0
0
1
0
Depreciation
-
-
0
0
0
0
0
-
Income Before Tax
-7
-16
-1
-20
-17
-21
-12
-6
Income Tax Expense
0
0
0
0
0
0
0
0
Net Income
-7
-16
-1
-20
-17
-21
-13
-6
Net Profit Margin
-80.44%
-290.69%
-32.16%
-474.16%
-316.55%
-422.08%
-257.79%
0.00%

Qualigen Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-3
-2
-2
-2
-1
-1
0
-1
-1
Operating Cash Flow
-2
0
-5
0
-1
-1
-2
-2
-1
Investing Cash Flow
0
4
0
-
0
-1
-
-1
-1
Financing Cash Flow
0
0
0
0
1
3
4
4
2
Change in Cash
-3
0
-1
0
0
0
0
0
0

Qualigen Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-18
-7
-16
-1
-20
-17
-21
-12
-6
Operating Cash Flow
-15
-7
-13
0
-9
-14
-13
-10
-6
Investing Cash Flow
0
0
0
0
0
0
0
4
-1
Financing Cash Flow
6
22
5
0
33
8
2
0
9
Change in Cash
-8
15
-14
0
0
-6
-10
-6
0

Global Institutional Holdings in Qualigen Therapeutics Inc

Funds
Holdings
LLBH Private Wealth Management, LLC
0.59%
Tower Research Capital LLC
0.07%
BlackRock Inc
0.03%
HARBOUR INVESTMENTS, INC.
0.02%
Group One Trading, LP
0%

Qualigen Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 21 September

    Mon, 06:29 AM

    -

    Faraday Future's YT Jia invests $4 million in Qualigen Therapeutics, acquiring about 7% of common stock.

Insights on Qualigen Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, QLGN stock has moved up by 38.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 132.3% return, outperforming this stock by 189.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 809.6% return, outperforming this stock by 906.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 7.94M → 2.23M (in $), with an average decrease of 71.8% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -855.82K → -1.68M (in $), with an average decrease of 96.9% per quarter

About Qualigen Therapeutics Inc

Qualigen Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing treatments for adult and pediatric cancers. The Company’s business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program (Pan-RAS). Its lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells (such as pancreatic cancer). Its Pan-RAS program, which is at the preclinical stage, consists of a family of rat sarcoma virus (RAS) oncogene protein-protein interaction inhibitor small molecules inhibits or block mutated RAS genes’ proteins from binding to their effector proteins thereby leaving the proteins from the mutated RAS unable to cause further harm. Its QN-302 is in a Phase 1a clinical trial.
OrganisationQualigen Therapeutics Inc
Headquarters5857 Owens Avenue, Carlsbad, CA, United States, 92008
IndustryHealth Technology
CEOMr. Kevin A. Richardson II
E-voting on sharesClick here to vote

Key Management of Qualigen Therapeutics Inc

Name

Title

Mr. Kevin A. Richardson II

Interim CEO, Chief Accounting Officer & Chairman of the Board

Mr. Michael S. Poirier

Chief Operating Officer

Mr. Christopher L. Lotz

VP of Finance & Corporate Secretary

Mr. Jiawei Wang

Co-Chief Executive Officer

Mr. Koti Meka

Chief Financial Officer

FAQs

What is Qualigen Therapeutics Inc share price today?

Qualigen Therapeutics Inc share price today is $3.89 as on at the close of the market. Qualigen Therapeutics Inc share today touched a day high of $4.06 and a low of $3.64.

What is the 52 week high and 52 week low for Qualigen Therapeutics Inc share?

Qualigen Therapeutics Inc share touched a 52 week high of $10.45 on and a 52 week low of $1.61 on . Qualigen Therapeutics Inc stock price today i.e. is closed at $3.89,which is 62.78% down from its 52 week high and 141.61% up from its 52 week low.

What is Qualigen Therapeutics Inc's market capitalisation today?

Qualigen Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Qualigen Therapeutics Inc Stock (QLGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Qualigen Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Qualigen Therapeutics Inc Shares that will get you 0.3856 shares as per Qualigen Therapeutics Inc share price of $3.89 per share as on October 21, 2025 at 1:29 am IST.

What is the minimum amount required to buy Qualigen Therapeutics Inc Stock (QLGN) from India?

Indian investors can start investing in Qualigen Therapeutics Inc (QLGN) shares with as little as ₹87.9 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.00 in Qualigen Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Qualigen Therapeutics Inc share’s latest price of $3.89 as on October 21, 2025 at 1:29 am IST, you will get 2.5707 shares of Qualigen Therapeutics Inc. Learn more about fractional shares .

What are the returns that Qualigen Therapeutics Inc has given to Indian investors in the last 5 years?

Qualigen Therapeutics Inc stock has given -99.82% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?